Moderna will hold its annual meeting of shareholders virtually on May 6, 2026, via www.virtualshareholdermeeting.com/MRNA2026. Shareholders will vote on electing two Class II directors to serve three-year terms expiring at the 2029 annual meeting. The meeting will also include a non-binding advisory vote on the compensation of Moderna’s named executive officers. In addition, shareholders will vote on a non-binding advisory proposal on the frequency of future advisory votes on executive compensation, and on ratifying the appointment of Ernst & Young as the independent registered public accounting firm for 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moderna Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001308179-26-000081), on March 16, 2026, and is solely responsible for the information contained therein.
Comments